Cambridge BioScience is launching the new MaxArray product range - a tissue microarray system from Zymed laboratories for use in proteomic research.
Cambridge BioScience is launching the new MaxArray product range - a tissue microarray system from Zymed laboratories for use in proteomic research.
MaxArray's innovative assay technology allows 60 tissue cores to be stained on just one slide, saving time and reagents over the more conventional method of staining 60 tissues on 60 slides.
Each tissue on the slide receives identical treatment, virtually eliminating the experimental variation that normally occurs when staining multiple slides due to differences in incubation times, reagents and other factors. Also, the MaxArray tissue microarray system can be used to rapidly and simply assess an antibody for species cross reactivity or to check different tissues for the presence of a specific antigen.
Tissue microarrays are paraffin-embedded and can be used in a variety of IHC and ISH applications including antibody screening, protein expression analysis, tissue specificity of proteins, phenotype versus genotype analysis, RNA or DNA in situ-Hybridisation (FISH or CISHT).
The MaxArray range includes: Human normal tissue microarray slides; breast receptor control cell microarrays; colorectal cancer tissue microarrays, HPV control cell microarrays; a custom tissue microarray service; and animal tissue microarray blocks and slides.
MaxArray tissue microarrays are constructed by removing tissues of interest from archived paraffin blocks.
These tissues are melted together into a homogeneous paraffin block that can be cut and mounted on slides.
Cambridge BioScience supplies the majority of Zymed's MaxArray products in both block format and as ready-to-use slides.
